Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - OtherShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Leases (2019 - 2025)

Fortress Biotech has reported Leases over the past 7 years, most recently at $12.3 million for Q4 2025.

  • Quarterly results put Leases at $12.3 million for Q4 2025, down 11.25% from a year ago — trailing twelve months through Dec 2025 was $12.3 million (down 11.25% YoY), and the annual figure for FY2025 was $12.3 million, down 11.25%.
  • Leases for Q4 2025 was $12.3 million at Fortress Biotech, roughly flat from $12.3 million in the prior quarter.
  • Over the last five years, Leases for FBIO hit a ceiling of $20.1 million in Q1 2021 and a floor of $12.3 million in Q4 2025.
  • Median Leases over the past 5 years was $17.7 million (2023), compared with a mean of $16.8 million.
  • Biggest five-year swings in Leases: increased 5.19% in 2022 and later dropped 19.19% in 2025.
  • Fortress Biotech's Leases stood at $19.0 million in 2021, then increased by 5.19% to $20.0 million in 2022, then fell by 15.01% to $17.0 million in 2023, then dropped by 18.42% to $13.9 million in 2024, then fell by 11.25% to $12.3 million in 2025.
  • The last three reported values for Leases were $12.3 million (Q4 2025), $12.3 million (Q3 2025), and $12.8 million (Q2 2025) per Business Quant data.